Augmedix, Inc.
Augmedix, Inc.（AUGX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
augx · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2025年3月24日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$3.50
Consensus
$2.67
+13.6% upside
Low
$1.50
Median: $3 · Last Close: $2.35
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$2.67
13.6% upside
High Target
$3.5
48.9%
Low Target
$1.5
-36.2%
Current Price
$2.35
as of today
Based on analyst price targets, the AUGX stock price prediction for the next 12 months ranges from $1.5 to $3.5. The consensus AUGX price forecast of $2.67 implies 13.6% upside from the current price of $2.35.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.35 | ↑ 0.12% |
1-day model range: $2.35–$2.35. Peak: $2.35 (+0.12%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AUGX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-07-22 | Lake Street | Downgrade ↓ | Buy→Hold |
| 2024-05-14 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2024-05-14 | Lake Street | Maintains | Buy→Buy |
| 2024-04-09 | Evercore ISI Group | Upgrade ↑ | In Line→Outperform |
| 2024-03-19 | Evercore ISI Group | Maintains | In Line→In Line |
| 2024-03-19 | Maxim Group | Maintains | Buy→Buy |
| 2023-05-16 | Benchmark | Maintains | Buy→Buy |
| 2023-05-15 | B. Riley Securities | Maintains | Buy→Buy |
| 2023-05-15 | Benchmark | Maintains | Buy→Buy |
| 2023-05-14 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Augmedix, Inc. (AUGX) stock. Of the recent 23 rating actions, 1 were upgrades and 2 were downgrades. 6 analysts currently cover AUGX.
分析师推荐趋势
AUGX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$31M
↓ 41.9% YoY
Revenue Next Year
$52M
↑ 67.7% YoY
EPS This Year
$-0.65
EPS Next Year
$-0.47
↓ 27.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast AUGX EPS of $-0.65 for the current fiscal year, based on estimates from 1 analysts. The AUGX revenue forecast is $31M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AUGX 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AUGX 的共识目标价为 $2.67（+13.6% 上行空间），分析师共识为 Buy。
AUGX 的短期预测（明日）为 $2.35（+0.12%）。
Augmedix, Inc. 在 NASDAQ 上市，代码 AUGX。AUGX 在 2027 年的整体展望偏积极，在覆盖分析师中约 67% 对应 Buy 共识。
常见问题
AUGX 预测 · 8 个问题根据 6 位华尔街分析师，AUGX 的 12 个月平均目标价为 $2.67，最高 $3.50、最低 $1.50。若有图表，中位目标价可在上方查看。相对当前价 $2.35，隐含约 +13.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.